Vaxart, Inc.
VXRT
$0.38
$0.00-0.16%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 72.41M | 39.73M | 20.88M | 15.19M | 4.93M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 72.41M | 39.73M | 20.88M | 15.19M | 4.93M |
| Cost of Revenue | 75.95M | 49.74M | 30.74M | 22.65M | 15.07M |
| Gross Profit | -3.53M | -10.01M | -9.87M | -7.47M | -10.13M |
| SG&A Expenses | 4.28M | 4.60M | 5.07M | 4.02M | 4.34M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 80.22M | 54.33M | 35.81M | 26.68M | 19.41M |
| Operating Income | -7.81M | -14.60M | -14.94M | -11.49M | -14.48M |
| Income Before Tax | -8.12M | -14.97M | -15.50M | -11.81M | -14.06M |
| Income Tax Expenses | 17.00K | 20.00K | 95.00K | 176.00K | 18.00K |
| Earnings from Continuing Operations | -8.14M | -14.99M | -15.59M | -11.99M | -14.08M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.14M | -14.99M | -15.59M | -11.99M | -14.08M |
| EBIT | -7.81M | -14.60M | -14.94M | -11.49M | -14.48M |
| EBITDA | -5.73M | -12.41M | -12.69M | -9.26M | -12.25M |
| EPS Basic | -0.04 | -0.07 | -0.07 | -0.05 | -0.06 |
| Normalized Basic EPS | -0.02 | -0.04 | -0.04 | -0.03 | -0.04 |
| EPS Diluted | -0.04 | -0.07 | -0.07 | -0.05 | -0.06 |
| Normalized Diluted EPS | -0.02 | -0.04 | -0.04 | -0.03 | -0.04 |
| Average Basic Shares Outstanding | 228.93M | 228.37M | 227.92M | 227.58M | 227.45M |
| Average Diluted Shares Outstanding | 228.93M | 228.37M | 227.92M | 227.58M | 227.45M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |